Literature DB >> 25409594

Reductions in frontocortical cytokine levels are associated with long-lasting alterations in reward valuation after methamphetamine.

Alexandra Stolyarova1, Andrew B Thompson1, Ruth M Barrientos2, Alicia Izquierdo1.   

Abstract

Alterations in reward valuation are thought to have a central role at all stages of the addiction process. We previously reported work aversion in an effortful T-maze task following a binge exposure to methamphetamine, and no such changes in effort following escalating doses. Limitations of the T-maze task include its two available options, with an effort requirement, in the form of increasing barrier height, varying incrementally as a function of time, and reward magnitudes held constant. Reward preferences and choices, however, are likely affected by the number of options available and the manner in which alternatives are presented. In the present experiment, we investigated the long-lasting, off-drug effects of methamphetamine on reward choices in a novel effortful maze task with three possible courses of action, each associated with different effort requirements and reward magnitudes. Neuroinflammatory responses associated with drug exposure, proposed as one of the mechanisms contributing to suboptimal choices on effort-based tasks, were also examined. We investigated region-specific changes in pro- and anti-inflammatory markers in the mesocorticolimbic pathway after methamphetamine, and their relationship with animals' reward choices. We observed long-lasting, increased sensitivity to differences in reward magnitude in the methamphetamine group: animals were more likely to overcome greater effort costs to obtain larger rewards on our novel effortful maze task. These behavioral changes were strongly predicted by pronounced decreases in frontocortical cytokines, but not amygdalar or striatal markers. The present results provide the first evidence that neuroinflammatory processes are associated with alterations in reward valuation during protracted drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25409594      PMCID: PMC4367468          DOI: 10.1038/npp.2014.309

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  52 in total

Review 1.  Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Authors:  Kenneth H Clark; Clayton A Wiley; Charles W Bradberry
Journal:  Neurotox Res       Date:  2012-06-20       Impact factor: 3.911

Review 2.  Time course of cytokine levels in sepsis.

Authors:  L G Thijs; C E Hack
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

3.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

4.  A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Authors:  Paul J Fletcher; Catherine C Tenn; Judy Sinyard; Zoë Rizos; Shitij Kapur
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

5.  Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.

Authors:  Minoru Narita; Mayumi Miyatake; Masahiro Shibasaki; Makoto Tsuda; Schuichi Koizumi; Michiko Narita; Yoshinori Yajima; Kazuhide Inoue; Tsutomu Suzuki
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

6.  Comparison of single-dose and extended methamphetamine administration on reversal learning in rats.

Authors:  Alisa R Kosheleff; Danilo Rodriguez; Steve J O'Dell; John F Marshall; Alicia Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  2012-07-04       Impact factor: 4.530

7.  Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.

Authors:  Minoru Narita; Mayumi Miyatake; Michiko Narita; Masahiro Shibasaki; Keiko Shindo; Atsushi Nakamura; Naoko Kuzumaki; Yasuyuki Nagumo; Tsutomu Suzuki
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

8.  Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area.

Authors:  D Beitner-Johnson; X Guitart; E J Nestler
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards.

Authors:  Matthew R Roesch; Donna J Calu; Geoffrey Schoenbaum
Journal:  Nat Neurosci       Date:  2007-11-18       Impact factor: 24.884

10.  Methamphetamine causes microglial activation in the brains of human abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Genichi Sugihara; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Yasuhide Iwata; Kenji J Tsuchiya; Shiro Suda; Katsuaki Suzuki; Masayoshi Kawai; Kiyokazu Takebayashi; Shigeyuki Yamamoto; Hideo Matsuzaki; Takatoshi Ueki; Norio Mori; Mark S Gold; Jean L Cadet
Journal:  J Neurosci       Date:  2008-05-28       Impact factor: 6.167

View more
  8 in total

1.  Chronic ethanol consumption: role of TLR3/TRIF-dependent signaling.

Authors:  Gizelle M McCarthy; Anna S Warden; Courtney R Bridges; Yuri A Blednov; R Adron Harris
Journal:  Addict Biol       Date:  2017-08-25       Impact factor: 4.280

2.  Steep effort discounting of a preferred reward over a freely-available option in prolonged methamphetamine withdrawal in male rats.

Authors:  Andrew B Thompson; Julian Gerson; Alexandra Stolyarova; Amador Bugarin; Evan E Hart; J David Jentsch; Alicia Izquierdo
Journal:  Psychopharmacology (Berl)       Date:  2017-06-06       Impact factor: 4.530

3.  Methamphetamine blocks exercise effects on Bdnf and Drd2 gene expression in frontal cortex and striatum.

Authors:  Andrew B Thompson; Alexandra Stolyarova; Zhe Ying; Yumei Zhuang; Fernando Gómez-Pinilla; Alicia Izquierdo
Journal:  Neuropharmacology       Date:  2015-08-31       Impact factor: 5.250

Review 4.  The basolateral amygdala in reward learning and addiction.

Authors:  Kate M Wassum; Alicia Izquierdo
Journal:  Neurosci Biobehav Rev       Date:  2015-09-02       Impact factor: 8.989

5.  Partial MHC/neuroantigen peptide constructs attenuate methamphetamine-seeking and brain chemokine (C-C motif) ligand 2 levels in rats.

Authors:  Jennifer M Loftis; Tommy Navis; Jonathan Taylor; Rebekah Hudson; Ulziibat Person; K Matthew Lattal; Arthur A Vandenbark; Renee Shirley; Marilyn Huckans
Journal:  Eur J Pharmacol       Date:  2020-05-13       Impact factor: 4.432

Review 6.  The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders.

Authors:  Ekaterina Dobryakova; Helen M Genova; John DeLuca; Glenn R Wylie
Journal:  Front Neurol       Date:  2015-03-12       Impact factor: 4.003

7.  Distinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthood.

Authors:  Alexandra Stolyarova; Alicia Izquierdo
Journal:  Front Behav Neurosci       Date:  2015-05-07       Impact factor: 3.558

8.  Mammary tumors suppress aging-induced neuroinflammation in female Balb/c mice.

Authors:  Ruth M Barrientos; Lindsay D Strehle; Ashley A Lahoud; Leah M Pyter
Journal:  Compr Psychoneuroendocrinol       Date:  2020-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.